Abstract | BACKGROUND AND OBJECTIVES: STUDY DESIGN: Forty-six patients with a clinical diagnosis of chancroid were randomly divided into 3 groups. Sixteen patients received ciprofloxacin, whereas 15 each received erythromycin and cotrimoxazole. Patients were seen on day 7, 14, and if needed day 21. Clinical response was noted in terms of cure, improvement, or failure. RESULTS: CONCLUSION:
|
Authors | P D'Souza, R K Pandhi, N Khanna, A Rattan, R S Misra |
Journal | Sexually transmitted diseases
(Sex Transm Dis)
Vol. 25
Issue 6
Pg. 293-5
(Jul 1998)
ISSN: 0148-5717 [Print] United States |
PMID | 9662762
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Bacterial Agents
- Anti-Infective Agents
- Anti-Infective Agents, Urinary
- Ciprofloxacin
- Erythromycin
- Trimethoprim, Sulfamethoxazole Drug Combination
|
Topics |
- Adult
- Anti-Bacterial Agents
(therapeutic use)
- Anti-Infective Agents
(therapeutic use)
- Anti-Infective Agents, Urinary
(therapeutic use)
- Chancroid
(drug therapy)
- Ciprofloxacin
(therapeutic use)
- Erythromycin
(therapeutic use)
- Female
- Humans
- Male
- Treatment Outcome
- Trimethoprim, Sulfamethoxazole Drug Combination
(therapeutic use)
|